Chegg (NYSE:CHGG), which provides online education tools to students, recently reported disappointing third-quarter results, and the company is facing very steep macro challenges. Despite the sharp decline of CHGG stock, its valuation remains elevated, given the firm’s growth outlook, its macro issues and the relatively low barriers to entry in its sector. Source: Casimiro PT
0 Comments
During tumultuous market periods, such as the one that has taken over since the newest variant of Covid-19 was discovered, investors tend to flock to safety. That can mean different things to different investors, but for dividend investors, the safety of reliable payouts can mean less volatility in one’s portfolio during periods of market weakness.
0 Comments
Catherine Wood, chief executive officer of ARK Investment Management LLC, speaks during the Milken Institute Global Conference in Beverly Hills, California, on Monday, Oct. 18, 2021. Kyle Grillot | Bloomberg | Getty Images It’s been a dismal week for Cathie Wood’s flagship fund, Ark Innovation, that’s left nearly all of her holdings in bear market.
0 Comments
I recommended Moderna (NASDAQ:MRNA) stock in late 2020 as part of a decade-long trend.  But MRNA stock has been taken over by events surrounding the company’s COVID-19 vaccine. Source: Shutterstock Through the first three quarters of 2021, Moderna racked up $11.26 billion in sales. Analysts expect another $5.9 billion to come rolling in for Q4.
0 Comments
In this article NOC Concept art of a “Starlab” space station Nanoracks NASA awarded a trio of companies with contracts to develop private space stations, as the agency prepares for the retirement of the International Space Station. Jeff Bezos’ Blue Origin, Northrop Grumman, and Nanoracks were awarded a combined $415.6 million under NASA’s Commercial LEO
0 Comments